Rancho Santa Fe, CA, United States of America

Charles Stanford Harmon


Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):

Title: Innovator Spotlight: Charles Stanford Harmon

Introduction

Charles Stanford Harmon is an esteemed inventor based in Rancho Santa Fe, California, known for his significant contributions to the field of metabolic disease treatment. With a remarkable portfolio of two patents, Harmon has been instrumental in developing innovative solutions that target serious health conditions.

Latest Patents

Harmon’s latest inventions include breakthrough technologies focused on malonyl-CoA decarboxylase inhibitors. His first patent, titled "Azole Compounds as Malonyl-CoA Decarboxylase Inhibitors for Treating Metabolic Diseases," delineates methods of treating various metabolic diseases by utilizing specific compounds and their prodrugs. These advancements specifically address cardiovascular diseases, diabetes, cancers, acidosis, and obesity by effectively inhibiting malonyl-CoA decarboxylase (MCD).

The second patent, "Method for Preparing Imidazole Derivatives," outlines methods for the prophylaxis, management, and treatment of diseases that are modulated by MCD inhibition. This invention emphasizes the administration of a composition with an active compound to combat several health issues, thus contributing significantly to medical science.

Career Highlights

Harmon is affiliated with Chugai Seiyaku Kabushiki Kaisha, a company recognized for its commitment to pharmaceutical innovation. Throughout his career, he has dedicated himself to advancing healthcare solutions through research and development focused on metabolic diseases.

Collaborations

He has collaborated with notable colleagues such as Thomas Arrhenius and Jie Fei Cheng, leveraging their collective expertise to accelerate innovation within the pharmaceutical landscape. These partnerships have fostered an environment ripe for groundbreaking research and the development of impactful medical solutions.

Conclusion

Charles Stanford Harmon exemplifies the spirit of innovation through his work in combating serious metabolic diseases. His contributions, particularly in the realm of malonyl-CoA decarboxylase inhibitors, could pave the way for revolutionary treatments that enhance patient outcomes. As a dedicated inventor at Chugai Seiyaku Kabushiki Kaisha, Harmon continues to inspire advancements in medical science, marking him as a pivotal figure in contemporary healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…